Joshua Bauml, MD

Articles

Dr. Bauml on the Utility of Liquid Biopsy in Metastatic NSCLC

January 28th 2020

Joshua Bauml, MD, discusses the utility of liquid biopsy in metastatic non–small cell lung cancer.

Dr. Bauml on the Use of Immunotherapy in Oligometastatic NSCLC

June 6th 2019

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the use of immunotherapy in oligometastatic non–small cell lung cancer.

Dr. Bauml on Locally Ablative Therapy in Oligometastatic NSCLC

May 8th 2019

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the use of locally ablative therapy in patients with oligometastatic non–small cell lung cancer.

Dr. Bauml on Treatment For Oligometastatic NSCLC

September 28th 2018

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the treatment of patients with oligometastatic non–small cell lung cancer.

Dr. Bauml on Emerging Biomarkers in NSCLC

July 27th 2018

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses emerging biomarkers in non–small cell lung cancer (NSCLC).

Dr. Bauml on HPV Vaccination for Head and Neck Cancer

February 22nd 2018

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses HPV vaccination for patients with HPV-related head and neck cancer.

Dr. Bauml Discusses Liquid Biopsies in Lung Cancer

January 26th 2018

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the role of liquid biopsies for patients with lung cancer.

Dr. Bauml Discusses Biomarkers in Head and Neck Cancer

January 11th 2018

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses biomarker development for patients with head and neck cancer.

Dr. Bauml Discusses the FLAURA Study in NSCLC

September 19th 2017

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the FLAURA trial in patients with EGFR-mutant non–small cell lung cancer.

Dr. Bauml on the Unmet Need in Head and Neck Cancer

August 18th 2017

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses an unmet need for patients with head and neck cancer.

x